An Equine Infectious Anemia Virus Variant Superinfects Cells through Novel Receptor Interactions
- 1 October 2008
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 82 (19), 9425-9432
- https://doi.org/10.1128/jvi.01142-08
Abstract
Wild-type strains of equine infectious anemia virus (EIAV) prevent superinfection of previously infected cells. A variant strain of virus that spontaneously arose during passage, EIAV vMA-1c , can circumvent this mechanism in some cells, such as equine dermis (ED) cells, but not in others, such as equine endothelial cells. EIAV vMA-1c superinfection of ED cells results in a buildup of unintegrated viral DNA and rapid killing of the cell monolayer. Here, we examined the mechanism of resistance that is used by EIAV to prevent superinfection and explored the means by which EIAV vMA-1c overcomes this restriction. We found that the cellular receptor used by EIAV, equine lentivirus receptor 1 (ELR1), remains on the surface of cells chronically infected with EIAV, suggesting that wild-type EIAV interferes with superinfection by masking ELR1. The addition of soluble wild-type SU protein to the medium during infection blocked infection by wild-type strains of virus, implicating SU as the viral protein responsible for interfering with virion entry into previously infected cells. Additionally, interference of wild-type EIAV binding to ELR1 by the addition of either anti-ELR1 antibodies or the ELR1 ectodomain prevented entry of the wild-type strains of EIAV into two permissive cell populations. Many of these same interference treatments prevented EIAV vMA-1c infection of endothelial cells but only modestly affected the ability of EIAV vMA-1c to enter and kill previously infected ED cells. These findings indicate that EIAV vMA-1c retains the ability to use ELR1 for entry and suggest that this virus can interact with an additional, unidentified receptor to superinfect ED cells.Keywords
This publication has 26 references indexed in Scilit:
- Development and Characterization of an Equine Infectious Anemia Virus Env-Pseudotyped Reporter VirusClinical and Vaccine Immunology, 2008
- Equine Infectious Anemia Virus Entry Occurs through Clathrin-Mediated EndocytosisJournal of Virology, 2008
- Mapping of Equine Lentivirus Receptor 1 Residues Critical for Equine Infectious Anemia Virus Envelope BindingJournal of Virology, 2008
- Contribution of Vpu, Env, and Nef to CD4 Down-Modulation and Resistance of Human Immunodeficiency Virus Type 1-Infected T Cells to SuperinfectionJournal of Virology, 2006
- Linkage of Reduced Receptor Affinity and Superinfection to Pathogenesis ofTR1.3 Murine Leukemia VirusJournal of Virology, 2006
- Endocytosis and a Low-pH Step Are Required for Productive Entry of Equine Infectious Anemia VirusJournal of Virology, 2005
- Adaptive Immunity Is the Primary Force Driving Selection of Equine Infectious Anemia Virus Envelope SU Variants during Acute InfectionJournal of Virology, 2004
- Characterization of a Cytolytic Strain of Equine Infectious Anemia VirusJournal of Virology, 2003
- Two Functionally Distinct Forms of a Retroviral Receptor Explain the Nonreciprocal Receptor Interference among Subgroups B, D, and E Avian Leukosis VirusesJournal of Virology, 2001
- Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: Mechanism for persistence in AIDSCell, 1988